Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 44

1.

Urinary Metabolites of Green Tea as Potential Markers of Colonization Resistance to Pathogenic Gut Bacteria in Mice.

Obrenovich ME, Jaskiw GE, Mana TSC, Bennett CP, Cadnum J, Donskey CJ.

Pathog Immun. 2019 Nov 14;4(2):271-293. doi: 10.20411/pai.v4i2.335. eCollection 2019.

2.

The phenolic interactome and gut microbiota: opportunities and challenges in developing applications for schizophrenia and autism.

Jaskiw GE, Obrenovich ME, Donskey CJ.

Psychopharmacology (Berl). 2019 May;236(5):1471-1489. doi: 10.1007/s00213-019-05267-3. Epub 2019 Jun 13. Review.

PMID:
31197432
3.

Leaky Gut, Leaky Brain?

Obrenovich MEM.

Microorganisms. 2018 Oct 18;6(4). pii: E107. doi: 10.3390/microorganisms6040107. Review.

4.

Quantification of phenolic acid metabolites in humans by LC-MS: a structural and targeted metabolomics approach.

Obrenovich ME, Donskey CJ, Schiefer IT, Bongiovanni R, Li L, Jaskiw GE.

Bioanalysis. 2018 Oct;10(19):1591-1608. doi: 10.4155/bio-2018-0140.

PMID:
30295550
5.

Targeted Metabolomics Analysis Identifies Intestinal Microbiota-Derived Urinary Biomarkers of Colonization Resistance in Antibiotic-Treated Mice.

Obrenovich ME, Tima M, Polinkovsky A, Zhang R, Emancipator SN, Donskey CJ.

Antimicrob Agents Chemother. 2017 Jul 25;61(8). pii: e00477-17. doi: 10.1128/AAC.00477-17. Print 2017 Aug.

6.

Fecal Microbiota Transplantation by Freeze-Dried Oral Capsules for Recurrent Clostridium difficile Infection.

Hecker MT, Obrenovich ME, Cadnum JL, Jencson AL, Jain AK, Ho E, Donskey CJ.

Open Forum Infect Dis. 2016 May 5;3(2):ofw091. eCollection 2016 Apr. No abstract available.

7.

The role of trace elements, thiamin (e) and transketolase in autism and autistic spectrum disorder.

Obrenovich ME, Shola D, Schroedel K, Agrahari A, Lonsdale D.

Front Biosci (Elite Ed). 2015 Jan 1;7:229-41. Review.

PMID:
25553376
8.

Link between cancer and Alzheimer disease via oxidative stress induced by nitric oxide-dependent mitochondrial DNA overproliferation and deletion.

Aliev G, Obrenovich ME, Tabrez S, Jabir NR, Reddy VP, Li Y, Burnstock G, Cacabelos R, Kamal MA.

Oxid Med Cell Longev. 2013;2013:962984. doi: 10.1155/2013/962984. Epub 2013 Apr 3. Review.

9.

Oxidative stress induced mitochondrial DNA deletion as a hallmark for the drug development in the context of the cerebrovascular diseases.

Aliev G, Li Y, Palacios HH, Obrenovich ME.

Recent Pat Cardiovasc Drug Discov. 2011 Sep;6(3):222-41. Review.

PMID:
21906026
10.

Altered heavy metals and transketolase found in autistic spectrum disorder.

Obrenovich ME, Shamberger RJ, Lonsdale D.

Biol Trace Elem Res. 2011 Dec;144(1-3):475-86. doi: 10.1007/s12011-011-9146-2. Epub 2011 Jul 14.

PMID:
21755304
11.

Effects of coenzyme Q and creatine supplementation on brain energy metabolism in rats exposed to chronic cerebral hypoperfusion.

Horecký J, Gvozdjáková A, Kucharská J, Obrenovich ME, Palacios HH, Li Y, Vančová O, Aliev G.

Curr Alzheimer Res. 2011 Dec;8(8):868-75.

PMID:
21592049
12.

Antioxidants in health, disease and aging.

Obrenovich ME, Li Y, Parvathaneni K, Yendluri BB, Palacios HH, Leszek J, Aliev G.

CNS Neurol Disord Drug Targets. 2011 Mar;10(2):192-207. Review.

PMID:
21226664
13.

Implication of oncogenic signaling pathways as a treatment strategy for neurodegenerative disorders - contemporary approaches.

Sieradzki A, Yendluri BB, Palacios HH, Parvathaneni K, Reddy VP, Obrenovich ME, Gąsiorowski K, Leszek J, Aliev G.

CNS Neurol Disord Drug Targets. 2011 Mar;10(2):175-83. Review.

PMID:
21222633
14.

Mitochondrion-specific antioxidants as drug treatments for Alzheimer disease.

Palacios HH, Yendluri BB, Parvathaneni K, Shadlinski VB, Obrenovich ME, Leszek J, Gokhman D, Gąsiorowski K, Bragin V, Aliev G.

CNS Neurol Disord Drug Targets. 2011 Mar;10(2):149-62. Review.

PMID:
21222631
15.

Dysautonomia in autism spectrum disorder: case reports of a family with review of the literature.

Lonsdale D, Shamberger RJ, Obrenovich ME.

Autism Res Treat. 2011;2011:129795. doi: 10.1155/2011/129795. Epub 2011 May 31.

16.

The role of polyphenolic antioxidants in health, disease, and aging.

Obrenovich ME, Nair NG, Beyaz A, Aliev G, Reddy VP.

Rejuvenation Res. 2010 Dec;13(6):631-43. doi: 10.1089/rej.2010.1043. Epub 2010 Sep 6. Review.

PMID:
20818981
17.

Characterization of the prion protein in human urine.

Dagdanova A, Ilchenko S, Notari S, Yang Q, Obrenovich ME, Hatcher K, McAnulty P, Huang L, Zou W, Kong Q, Gambetti P, Chen SG.

J Biol Chem. 2010 Oct 1;285(40):30489-95. doi: 10.1074/jbc.M110.161794. Epub 2010 Jul 29.

18.

Oxidative Stress Induced Mitochondrial Failure and Vascular Hypoperfusion as a Key Initiator for the Development of Alzheimer Disease.

Aliev G, Palacios HH, Gasimov E, Obrenovich ME, Morales L, Leszek J, Bragin V, Solís Herrera A, Gokhman D.

Pharmaceuticals (Basel). 2010 Jan 19;3(1):158-187. Review.

19.

Brain mitochondria as a primary target in the development of treatment strategies for Alzheimer disease.

Aliev G, Palacios HH, Walrafen B, Lipsitt AE, Obrenovich ME, Morales L.

Int J Biochem Cell Biol. 2009 Oct;41(10):1989-2004. doi: 10.1016/j.biocel.2009.03.015. Epub 2009 Apr 5. Review.

PMID:
19703659
20.

Nitric oxide as an initiator of brain lesions during the development of Alzheimer disease.

Aliev G, Palacios HH, Lipsitt AE, Fischbach K, Lamb BT, Obrenovich ME, Morales L, Gasimov E, Bragin V.

Neurotox Res. 2009 Oct;16(3):293-305. doi: 10.1007/s12640-009-9066-5. Epub 2009 May 30.

PMID:
19526276

Supplemental Content

Loading ...
Support Center